Business Wire

MIRJAM-HELIN-COMPETITION

8.2.2024 12:01:37 CET | Business Wire | Press release

Share
Singers From 25 Countries to the International Mirjam Helin Competition

56 talented young singers were selected to compete for the first prize of 50,000 euro in the Mirjam Helin competition in Helsinki, Finland next June.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240208343535/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

One of the 2019 winners Johanna Wallroth singing with the Finnish Radio Symphony Orchestra and conductor Hannu Lintu. Photo by Heikki Tuuli.

Based on video pre-screening, the Mirjam Helin competition selected 56 out of 485 applicants for the competition in Helsinki next June. Altogether 61 nationalities were represented among the applicants.

Soile Isokoski, opera singer and chair of the Mirjam Helin competition jury is delighted to see that the competition attracted such highly promising and talented singers.

“Naturally, the first criterion is the applicant’s voice, but this is just the starting point. We look for singers who perform the music as it is intended but who also go beyond the notes, bring the song to life and master all the different genres. Verdi and Mozart cannot be sung in the same way,” Isokoski says.

South Korea has the highest number of applicants accepted to the competition, thirteen in total. Four of the competitors are from Finland. The competitors represent 25 nationalities, with participants from countries such as Armenia, Germany, Costa Rica, China, the United States, Croatia and Australia. For a full list of competitors, see mirjamhelin.fi.

The preliminary competition with piano accompaniment will take place from 3 to 6 June 2024. The jury selects 16–20 singers for the semifinals, and six will be eligible for the orchestral finals on 12 June. In the orchestral finals, the singers will perform with the Helsinki Philharmonic, led by Sir Mark Elder.

The jury members are soprano Dawn Upshaw, mezzosoprano Randi Stene, baritone Bo Skovhus, pianist Keval Shah and chair, soprano Soile Isokoski.

The Mirjam Helin competition is celebrating its 40th anniversary this year. The winner will be awarded the first prize of 50,000 euro; the second prize is 40,000 euro, the third prize 30,000 euro, and the other three finalists will receive 10,000 euro each. The finalists will also have opportunities to perform at Finnish music festivals and with Finnish orchestras.

The Finnish Cultural Foundation has been organizing the international Mirjam Helin competition since 1984. The competition is founded on Mirjam ja Hans Helin’s large donation. Professor Mirjam Helin’s (1911–2006) aim was to establish an international singing competition in Finland and to make it the most prestigious competition globally.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240208343535/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery26.2.2026 12:49:00 CET | Press release

The Wyss Center for Bio and Neuroengineering Geneva announced today the successful closing of the Seed financing round of Clee Medical SA, a Swiss neurotechnology spin-off developing ultra-high-resolution real-time intraoperative imaging for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, and Venture Kick joining existing investors Wyss Center Geneva. Clee Medical spun-out from Wyss Geneva’s Minimally Invasive Intracranial Access (MICA) research project in December 2024. Its flagship platform, Neuro Access, combines OCT imaging with advanced navigation to help neurosurgeons visualize brain anatomy and critical structures in real time during stereotactic procedures. “Clee Medical not only holds the promise of improving patient outcomes but also highlights Wyss Geneva’s dedication to bridging the gap between scientific discovery and real-world impact.” Dr. Erwin Böttinger, CEO, Wyss Geneva “Neurosurg

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants26.2.2026 12:30:00 CET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were issued on January 13, 2025, for proceeds of approximately $200 million. Upon exercise of these outstanding warrants, Compass Pathways is issuing 15,160,619 American Depositary Shares (“ADSs”) and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 19,898,829 ADSs. Compass Pathways currently intends to use the proceeds from these warrant exercises, together with its existing cash and cash equivalents, to fund ongoing COMP005 and COMP006 Phase 3 trials, its Phase 2b/3 trial of COMP360 in PTSD, acceleration of its commercial readiness activities, and for working capital and general corporate purposes. The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on Februar

BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership26.2.2026 12:00:00 CET | Press release

Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases of 33% and 40% from the prior-year periodsGlobal BRUKINSA (zanubrutinib) revenues of $1.1 billion and $3.9 billion for the fourth quarter and full year, increases of 38% and 49% from the prior-year periodsDiluted GAAP Earnings per American Depository Share (ADS) of $0.58 and $2.53 for the fourth quarter and full year; non-GAAP diluted Earnings per ADS of $1.95 and $8.09 for the fourth quarter and full yearFull year 2026 total revenue guidance of $6.2 billion to $6.4 billion BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the fourth quarter and full year 2025. “These strong financial results for the fourth quarter and full year 2025 underscore our continued evolution as a global oncology leader with durable competitive advantages in clinical development and manufacturing and one of the

ThreatAware Secures $25M from One Peak to Give Security Teams the Power to Build26.2.2026 11:00:00 CET | Press release

Bootstrapped to profitability and 100+ clients, ThreatAware launches its AI-powered security workspace that gives security teams the freedom to build exactly what they need. ThreatAware, the cyber asset management and cyber hygiene platform trusted by enterprises across sectors including retail, financial services, and energy, today announced it has raised $25 million in funding from One Peak, the growth equity firm specialising in high-growth software scale-ups. The investment will help ThreatAware scale its rapidly growing North American operations and accelerate its ambitious product roadmap, including the launch of ThreatAware's AI-powered security workspace. At the heart of ThreatAware's platform is its proprietary cyber asset management technology, which solves a problem most organisations don't even know they have. ThreatAware's data consistently reveals that, on average, 10% of devices accessing corporate networks go completely undetected by existing tools, while 30% of securit

Cyviz Unveils Containerized C2 Solution During HEIMDALL26.2.2026 11:00:00 CET | Press release

During Exercise HEIMDALL, organized by the Norwegian Joint Headquarters (FOH/NJHQ) this week, Cyviz is presenting its fully integrated, containerized solution for command, control, and collaboration environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226587573/en/ From deployment to operations: Cyviz’ container‑based C2 solution demonstrated during Exercise HEIMDALL. James Munt, Sales Director from Cyviz, took part in the demonstration. The solution is designed for secure, standardized, and agile operations, enabling operators to fight at the edge with assured information and supporting faster decision-making, in line with the company’s strategic focus on the defense and security sector. The container solution has been developed in collaboration with Nordic Shelter, providing the container platform. The modular platform combines control room technology, visualization, and software into one integrated system. It’s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye